SCHEMBL708464

SCHEMBL708464

FC1CCCC(F)C1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24425424 1.00
SCHEMBL1067063 0.82
SCHEMBL13618610 0.82
SCHEMBL1470109 0.82
SCHEMBL6451278 0.80 THRB (0.35)
SCHEMBL12540116 0.79
SCHEMBL12352143 0.79
SCHEMBL16844741 0.79
SCHEMBL21017220 0.78
SCHEMBL16892603 0.77 THRB (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0031708-B1 CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES THEREFOR ICI PHARMA (FR) 1984-06-13 EP claimed
EP-0075434-A2 Cephalosporins, their preparation and their pharmaceutical compositions ICI PHARMA (FR) 1983-03-30 EP claimed
EP-0071370-A2 Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them ICI PHARMA (FR) 1983-02-09 EP claimed
US-20250343048-A1 ETCHING METHOD RESONAC CORPORATION (JP) 2025-11-06 US disclosed
EP-4481794-A1 ETCHING METHOD Resonac Corporation (JP) 2024-12-25 EP disclosed
WO-2023157441-A1 ETCHING METHOD 株式会社レゾナック 2023-08-24 WO disclosed
CN-116514630-A Treatment method of fluorobenzene rectification residual liquid 浙江大洋生物科技集团股份有限公司 2023-08-01 CN disclosed
US-11150556-B2 Polymer of polyimide precursor, positive type photosensitive resin composition, negative type photosensitive resin composition, patterning process, method for forming cured film, interlayer insulating film, surface protective film, and electronic parts SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-10-19 US disclosed
EP-3601203-B1 PROCESS FOR SYNTHESIZING FLUORINATED CYCLIC ALIPHATIC COMPOUNDS UNIV MUENSTER WESTFAELISCHE WILHELMS (DE) 2021-04-07 EP disclosed
EP-2722924-B1 NON-AQUEOUS SOLVENT AND NON-AQUEOUS ELECTROLYTIC SOLUTION FOR ELECTRICAL STORAGE DEVICES, AND ELECTRICAL STORAGE DEVICE, LITHIUM SECONDARY BATTERY AND ELECTRIC DOUBLE-LAYER CAPACITOR EACH UTILIZING SAID NON-AQUEOUS SOLVENT AND SAID NON-AQUEOUS ELECTROLYTIC SOLUTION PANASONIC IP MAN CO LTD (JP) 2018-11-28 EP disclosed
EP-2722924-A1 NON-AQUEOUS SOLVENT AND NON-AQUEOUS ELECTROLYTIC SOLUTION FOR ELECTRICAL STORAGE DEVICES, AND ELECTRICAL STORAGE DEVICE, LITHIUM SECONDARY BATTERY AND ELECTRIC DOUBLE-LAYER CAPACITOR EACH UTILIZING SAID NON-AQUEOUS SOLVENT AND SAID NON-AQUEOUS ELECTROLYTIC SOLUTION Panasonic Corporation (JP) 2014-04-23 EP disclosed
US-20030096929-A1 Copolymers comprising low surface tension (meth) acrylates PPG INDUSTRIES OHIO, INC. 2003-05-22 US disclosed
WO-2003027159-A2 COMPOSITIONS CONTAINING A LOW SURFACE TENSION (METH)ACRYLATE CONTAINING BLOCK COPOLYMER PPG INDUSTRIES OHIO, INC. (US) 2003-04-03 WO disclosed
WO-2003027155-A1 COPOLYMERS COMPRISING LOW SURFACE TENSION (METH)ACRYLATES PPG INDUSTRIES OHIO, INC. (US) 2003-04-03 WO disclosed
US-4504478-A Cephalosporin-1-oxide derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (FR) 1985-03-12 US disclosed
US-4486426-A BACTERICIDAL ANTIBIOTICS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1984-12-04 US disclosed
US-4463173-A ANTIBIOTIC, BACTERICIDE ICI PHARMA (FR) 1984-07-31 US disclosed
EP-0031708-B1 CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES THEREFOR ICI PHARMA (FR) 1984-06-13 EP disclosed
EP-0075434-A2 Cephalosporins, their preparation and their pharmaceutical compositions ICI PHARMA (FR) 1983-03-30 EP disclosed
EP-0071370-A2 Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them ICI PHARMA (FR) 1983-02-09 EP disclosed